Calculated plasma medial effective concentration of propofol with and without magnesium sulfate at loss of consciousness
查看参考文献28篇
|
文摘
|
Background Perioperative disorder of magnesium, an important cation in the human body, may affect clinical anesthesia. The pharmacological data of propofol use, which is popularly used in the anesthesiology department and intensive care unit, is incomplete in Chinese patients. This study aimed to assess the effect of magnesium sulfate on the calculated plasma medial effective concentration (Cp50cal) of propofol at loss of response to command in Chinese females. Methods Fifty patients undergoing gynecological laparoscopic surgery were randomly divided into the control group and the magnesium group. Before induction, magnesium sulfate (30 mg/kg) or placebo (equal volume of 0.9% saline) was given to patients in the magnesium group or the control group, respectively. Propofol was infused using a target-controlled infusion system, with a target concentration for each patient decided by up-and-down sequential allocation. After the equilibration between target plasma concentration and effective-site concentration, the state of consciousness was assessed. For determination of serum magnesium and calcium concentration, blood samples were taken before induction, after induction and at the end of surgery. Results The Cp50cal was 2.52 μg/ml (2.47–2.57 μg/ml) for patients in the control group, and 2.46 μg/ml (2.41–2.51 μg/ml) for those in the magnesium group. A significant reduction of Cp50cal was observed (P=0.021). There was a significant difference between the serum magnesium concentrations after induction and at the end of the surgery (P <0.05). In the magnesium group, there was a trend toward decreasing after surgery, while in the control group, Cp50cal decreased significantly (P <0.01). Conclusions Cp50cal of propofol at loss of response to command was 2.52 μg/ml (2.47–2.57 μg/ml) for Chinese female adults in this study. Infusion of 30 mg/kg magnesium sulfate may reduce the Cp50cal of propofol at loss of consciousness, which implies that magnesium may enhance the pharmacological effects of propofol. |
|
来源
|
Chinese Medical Journal
,2011,124(7):997-1000 【核心库】
|
|
DOI
|
10.3760/cma.j.issn.0366-6999.2011.07.008
|
|
关键词
|
magnesium
;
propofol
;
medial effective concentration
|
|
地址
|
1.
Department of Anesthesiology, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, 100021
2.
Department of Anesthesiology, Peking Union MedicalUniversity Hospital, Beijing, 100730
|
|
语种
|
英文 |
|
文献类型
|
研究性论文 |
|
ISSN
|
0366-6999 |
|
学科
|
药学 |
|
文献收藏号
|
CSCD:4428499
|
参考文献 共
28
共2页
|
|
1.
Glass P S A. Nomenclature for computer-assisted infusion devices.
Anesthesiology,1997,86:1430-1431
|
CSCD被引
2
次
|
|
|
|
|
2.
Vuyk J. Pharmacodynamics of propofol in female patients.
Anesthesiology,1992,77:3-9
|
CSCD被引
7
次
|
|
|
|
|
3.
Kazama T. Reduction by fentanyl of the CP50 values of propofol and hemodynamic responses to various noxious stimuli.
Anesthesiology,1997,87:213-227
|
CSCD被引
27
次
|
|
|
|
|
4.
Schnider T. The influence of age on propofol pharmacodynamics.
Anesthesiology,1999,90:1502-1516
|
CSCD被引
1
次
|
|
|
|
|
5.
Orme R. Esmolol and anesthetic requirement for loss of responsiveness during propofol anesthesia.
Anesth Analg,2002,94:112-116
|
CSCD被引
7
次
|
|
|
|
|
6.
Leslie K. Mild core hypothermia and anesthetic requirement for loss of responsiveness during propofol anesthesia.
Anesth Analg,2002,94:1298-1303
|
CSCD被引
2
次
|
|
|
|
|
7.
Chortkoff B. Concentrations of desflurane and propofol that suppress response to command in humans.
Anesth Analg,1995,81:737-743
|
CSCD被引
2
次
|
|
|
|
|
8.
Smith C. The interaction of fentanyl on the CP50 of propofol for loss of consciousness and skin incision.
Anesthesiology,1994,8:820-828
|
CSCD被引
35
次
|
|
|
|
|
9.
Davidson J A. Effective concentration 50 for propofol with and without 67% nitrous oxide.
Acta Anaesthesiol Scand,1993,37:458-464
|
CSCD被引
1
次
|
|
|
|
|
10.
Choi J C. Intravenous magnesium sulfate administration reduces propofol infusion requirements during maintenance of propofol-N2O.
Anesthesiology,2002,97:1137-1141
|
CSCD被引
5
次
|
|
|
|
|
11.
Telci L. Evaluation of effects of magnesium sulfate in reducing intraoperative anaesthetic requirements.
Br J Anaesth,2002,89:594-598
|
CSCD被引
8
次
|
|
|
|
|
12.
Fuchs-Buder T. Interaction of magnesium sulfate with vecuronium-induced neuromuscular block.
Br J Anaesth,1995,74:405-409
|
CSCD被引
3
次
|
|
|
|
|
13.
Gupta K. Magnesium as an adjuvant during general anaesthesia.
Anaesthesia,2006,61:1058-1063
|
CSCD被引
7
次
|
|
|
|
|
14.
Marsh B. Pharmacokinetic model driven infusion of propofol in children.
Br J Anaesth,1991,67:41-48
|
CSCD被引
65
次
|
|
|
|
|
15.
Struys M R F. Ability of the bispectral index, autoregressive modeling with exogenous input-derived auditory evoked potentials, and predicted propofol concentrations to measure patient responsiveness during anesthesia with propofol and remifentanil.
Anesthesiology,2003,99:802-812
|
CSCD被引
1
次
|
|
|
|
|
16.
Xu Z. C50 for propofol-remifentanil target-controlled infusion and bispectral index at loss of consciousness and response to painful stimulus in Chinese patients: a multicenter clinical trial.
Anesth Analg,2009,108:478-483
|
CSCD被引
14
次
|
|
|
|
|
17.
Iseri L T. Magnesium: nature’s physiologic calcium blocker.
Am Heart J,1984,108:188-194
|
CSCD被引
8
次
|
|
|
|
|
18.
Evans R H. Mg2+-like selective antagonism of excitatory amino acid-induced responses by α, ε-diaminopimelic acid, D-α-maminoadipate and HA-966 in isolated spinal cord of frog and immature rat.
Brain Res,1978,148:536-542
|
CSCD被引
1
次
|
|
|
|
|
19.
Casey G. Perioperative nimodipine and postoperative analgesia.
Anesth Analg,2006,102:504-508
|
CSCD被引
2
次
|
|
|
|
|
20.
Zhao M. Subpopulation of dorsal horn neurons displays enhanced N-methyl-D-aspartate receptor function after chronic morphine exposure.
Anesthesiology,2006,104:815-825
|
CSCD被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问